利用聚多巴胺制备丹参注射液缓释制剂的研究
2020-08-19朱辰奇顾依周琴刘馨沈惠明陈志鹏
朱辰奇 顾依 周琴 刘馨 沈惠明 陈志鹏



摘要 目的:利用聚多巴胺(PDA)对丹参注射液中多成分进行负载,构建丹参注射液(SMI)缓释制剂(PDA-SMI)。方法:建立丹参注射液的原儿茶醛、迷迭香酸和丹酚酸B3种成分的分析方法并进行含量测定;制备PDA,在pH值2.5的条件下对SMI进行负载,制备PDA-SMI;对PDA-SMI体外释放行为进行考察。结果:SMI中原儿茶醛、迷迭香酸、丹酚酸B的浓度分别为0.344、0.214、0.262 mg/mL;PDA-SMI对原儿茶醛、迷迭香酸、丹酚酸B的载药量分别为8.59%,15.90%和20.57%;PDA-SMI中原儿茶醛、迷迭香酸、丹酚酸B体外累计释放率分别为84.05%,77.57%和63.12%。结论:PDA可以负载SMI的多种成分,载药量较高,并具有良好的缓释效应。
关键词 丹参注射液;聚多巴胺;缓释制剂;高效液相色谱法
Study on Preparation of Danshen Injection Sustained-release Preparation Using Polydopamine
ZHU Chenqi1,2,GU Yi2,ZHOU Qin1,LIU Xin1,SHEN Huiming1,CHEN Zhipeng2
(1 Department of Pharmacy,Suzhou Hospital Affiliated to Nanjing Medical University,Suzhou 215002,China; 2 School of Pharmacy,Nanjing University of Chinese Medicine,Nanjing 210023,China)
Abstract Objective:To use polydopamine(PDA)to carry out multiple components of Salvia miltiorrhiza injection,and to construct a slow-release preparation of Salvia miltiorrhiza injection(SMI)(PDA-SMI).Methods:Establish the analysis method of the three components of protocatechuic aldehyde,rosmarinic acid and salvianolic acid B of Salvia miltiorrhiza injection and determine the content; prepare PDA,load SMI under the condition of pH 2.5 to prepare PDA-SMI; The in vitro release behavior of PDA-SMI was investigated.Results:The concentrations of protocatechuic aldehyde,rosmarinic acid and salvianolic acid B in SMI were 0.344,0.214 and 0.262 mg/mL,respectively; the loading of protocatechuic aldehyde,rosmarinic acid and salvianolic acid B by PDA-SMI The doses were 8.59%,15.90% and 20.57% respectively; the cumulative release rates of protocatechuic aldehyde,rosmarinic acid and salvianolic acid B in PDA-SMI were 84.05%,77.57% and 63.12%,respectively.Conclusion:PDA can load multiple components of SMI and has a good sustained-release effect.
Keywords Salvia miltiorrhiza injection; Polydopamine; Sustained-release preparation; High performance liquid chromatography
中圖分类号:R283文献标识码:Adoi:10.3969/j.issn.1673-7202.2020.15.009
随着人口老龄化程度日益加深,人们生活方式和饮食结构的改变,心血管疾病成为了威胁人类健康的头号杀手[1]。Salviae Miltiorrhizae Radix et Rhizoma是唇形科丹参属植物丹参Salvia miltiorrhiza Bge.的干燥根和根茎[2]。研究表明,丹参中的多种成分对心血管可以发挥抗氧化、抗血小板聚集及心肌保护的作用[3-5]。丹参注射液(Salvia Miltiorrhiza Injection,SMI)是丹参水提醇沉后精制而成,是心肌梗死的住院患者使用频率最高的中药制剂,使用频率高达35.5%[6]。但是,SMI存在药物成分在体内代谢较快的问题,导致到达靶部位药量较少[7-8]。有必要设计中药新型制剂对SMI进行改善,能够负载SMI多成分的同时,具有一定缓释效应。
多巴胺可以在碱性环境下聚合形成聚多巴胺(Polydopamine,PDA)纳米粒[9]。PDA具有良好的生物相容性,可以对多种药物同时进行吸附[10-11]。本研究提出利用PDA对SMI中的多成分进行负载,构建中药新制剂PDA-SMI,赋予其缓释性能,有助于延长药物在体内滞留时间。……
